ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Tredan, O., Menetrier-Caux, C., Ray-Coquard, I., Garin, G., Cropet, C., Verronese, E., Bachelot, T., Rebattu, P., Heudel, P. E., Cassier, P., Chabaud, S., Croughs, T., Dupont, P., Cadore, A. C., ClapiLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv173
Date:
April, 2015
File:
PDF, 760 KB
english, 2015